Objectives To describe the cognitive and functional impairment in individuals with the first
episode of major depressive disorder (MDD) as compared to controls and individuals with …

Background Cognitive impairments are an emerging treatment target in mood disorders, but
currently there are no evidence‐based pro‐cognitive treatments indicated for patients in …

Objectives Cognitive impairment affects many patients with bipolar disorder (BD), and
treatments with replicated pro‐cognitive effects are lacking. This study aimed to assess the …

There is a pressing need for measures of real-life cognitive functioning in patients with mood
or psychotic disorders in clinical settings and treatment trials targeting cognition. We …

Background Cognitive deficits are common and disabling residual symptoms following
major depressive disorder (MDD) and are related to increased risk of relapse. Residual …

Background The current paper briefly summarizes the literature on the neurocognitive deficit
and its treatment in BD patients. Methods The material was chosen on the basis of previous …

Background Abnormalities in dopamine and norepinephrine signaling are implicated in
cognitive impairments in bipolar disorder (BD) and attention‐deficit hyperactivity disorder …

Objectives Identification of comorbid attention-deficit/hyperactivity disorder (ADHD) in
patients with bipolar disorder (BD) is complicated by overlapping cognitive symptoms and …

Background Maladaptive metacognitive beliefs are frequent during depressive states of
bipolar disorder (BD). Still, it is unclear whether they persist in remitted phases and play a …

The determinants of metacognition are still poorly understood in bipolar disorders (BD). We
aimed to examine the clinical determinants of metacognition, defined as the agreement …